alexa Regulation Of LncRNA-MIF In C-Myc Homeostasis
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

16th Global Annual Oncologists Meeting
April 24-25, 2017 Dubai, UAE

Mian Wu
University of Science and Technology of China, China
ScientificTracks Abstracts: J Cancer Sci Ther
DOI: 10.4172/1948-5956-C1-096
c-Myc is one of the most important proto-oncogenes and is activated in over half of human cancers. However, it remains unclear how the c-Myc protein level is regulated. Here we show that lncRNA-MIF (c-myc inhibitory factor), a c-Mycinduced long non-coding RNA, acts as a competing endogenous RNA (ceRNA) for miR-586 and reduces the inhibitory effect of shared miR-586 on Fbw7, an E3 ligase for c-Myc, leading to increased Fbw7 level and subsequent c-Myc degradation. This creates an autoregulatory feedback loop between c-Myc and Fbw7 that involves both a long and a micro noncoding RNAs. Interestingly, levels of all components of this network including c-Myc, lncRNA-MIF, miR-586 and Fbw7 are found to be higher in tumor cells than in normal cells. The c-Myc-lncRNA-MIF-miR-586-Fbw7 axis represents a novel mechanism by which c-Myc homeostasis is finely regulated. Additionally, lncRNA-MIF is able to inhibit the glycolysis and tumorgenesis via suppressing c-Myc.

Mian Wu has completed his graduation from Nanjing Normal University in 1981 (BS) and obtained his PhD degree from Columbia University, USA in 1988. He then continuously conducted his Post-doctoral research at Harvard University during 1988-1991. Thereafter, he moved to Singapore as an Assistant Professor at School of Biological Sciences of National University of Singapore. From 2000, he worked as a full Professor at University of Science and Technology of China in Hefei, Anhui. His research interests focus on molecular mechanisms for p53-regulated tumor development and regulation of non-coding RNA in tumor metabolism. He has published more than 60 research papers in international peer-reviewed journals with more than 2900 citations.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version